Despite a revolution in depression awareness and treatment in the 1990s and the approval of more than 20 drugs for the condition, many individuals still struggle with the condition. However, the recent discovery of new regions in the human genome associated with susceptibility to major depressive disorder (MDD) could pave the way for novel therapeutic strategies and improved diagnostics.
Hampton T. New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies. JAMA. 2018;320(1):20–21. doi:10.1001/jama.2017.12862
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: